首页> 外文期刊>Journal of biomolecular techniques :JBT. >Comparative microRNA Profiling by TaqMan Low Density Arrays and Affymetrix GeneChip miRNA 2.0 Arrays: An Evaluation of Platform Performance
【24h】

Comparative microRNA Profiling by TaqMan Low Density Arrays and Affymetrix GeneChip miRNA 2.0 Arrays: An Evaluation of Platform Performance

机译:TaqMan低密度阵列和Affymetrix GeneChip miRNA 2.0阵列的比较microRNA分析:平台性能评估

获取原文
获取外文期刊封面目录资料

摘要

Genome-wide miRNA level profiling platforms can be applied to measure aberrant post-transcriptional gene regulation in human diseases including cancer. To determine the relative miRNA abundance in paired total RNA samples from tumors and normal tissues from patients with aristolochic acid nephropathy (AAN) with upper urinary tract urothelial carcinomas (UUCs), we performed a systematic performance comparison between two prominent platforms: 1) the high-capacity quantitative PCR using Applied Biosystems megaplex RT primer pools for 754 human miRNAs from the miRBase v14 contents, analyzed by the microfluidics TaqMan Low Density Arrays (TLDA)) and 2) the semiquantitative Affymetrix GeneChip miRNA 2.0 arrays that cover 100 % miRBase v15 contents, with multi-species coverage corresponding to miRNAs of 131 organisms detected by 15,644 probe sets. Systematic data analysis of the TLDA results revealed a signature of 50 miRNAs differentially modulated (19 elevated and 31 reduced) in tumors versus unaffected tissues detected at a reasonable Pearson correlation by both profiling platforms, while there were also platform-specific discrepancies, especially when relative levels and the rank of all human miRNAs were compared. We conclude that for miRNA abundance profiling studies, the performance of these platforms is considerably comparable and we also address the possible sources of observed discrepancies. Next, we discuss the utility of the additional information provided by the broader Affymetrix array content such as the value of cross-reactivity among orthologous probes for non-human species and the value of additional probes for snoRNAs and scaRNAs and most importantly the extensive sets unique to pre-miRNA hairpins. Our study can serve as a useful starting point for specific platform recommendations offered to clients by a genomics shared resource laboratory. Articles from Journal of Biomolecular Techniques : JBT are provided here courtesy of The Association of Biomolecular Resource Facilities.
机译:全基因组miRNA水平分析平台可用于测量人类疾病(包括癌症)中异常的转录后基因调控。为了确定来自马兜铃酸肾病(AAN)和上尿路尿路上皮癌(UUC)患者的肿瘤和正常组织的配对总RNA样品中的相对miRNA丰度,我们在两个主要平台之间进行了系统的性能比较:1)高容量定量PCR,使用Applied Biosystems megaplex RT引物池针对miRBase v14内容中的754个人类miRNA,通过微流控TaqMan低密度阵列(TLDA)进行了分析)和2)半定量Affymetrix GeneChip miRNA 2.0阵列,涵盖了100%miRBase v15内容,其多物种覆盖范围对应于15644套探针组检测到的131种生物的miRNA。 TLDA结果的系统数据分析显示,两个分析平台以合理的Pearson相关性检测到的肿瘤中,相对于未受影响的组织,有50个miRNA的差异调节信号(升高19个,降低31个),同时也存在平台特异性差异,尤其是相对差异时比较了所有人类miRNA的水平和等级。我们得出结论,对于miRNA丰度分析研究,这些平台的性能相当可比,并且我们还解决了观察到的差异的可能来源。接下来,我们讨论由更广泛的Affymetrix阵列内容提供的附加信息的实用性,例如非人类直系同源探针之间的交叉反应值以及snoRNA和scaRNA附加探针的值,最重要的是,广泛的独特探针组到pre-miRNA发夹。我们的研究可以作为基因组共享资源实验室为客户提供的特定平台建议的有用起点。这里由生物分子资源设施协会提供了《生物分子技术杂志》上的文章:JBT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号